Recon: BMS buys cell therapy partner 2seventy bio for $286M; Zydus buys majority stake in French device maker Amplitude

• Former NIH director Francis Collins, once beloved in Washington, now worries for his safety there (STAT)
• Senators say Kennedy must disclose details on drugmaker connections (Bloomberg)
• US FDA Would See Another Austere Year With GOP Funding Bill, No PRV Reauthorization (Pink Sheet)
• GLP-1 Compounding: Court Backs US FDA Approach To Managing Drug Shortage List (Pink Sheet)
• States eye mRNA vaccine limits for a hesitant public (Politico)

• India's Zydus Lifesciences to buy 86% stake in French medical devices maker (Reuters)
• Bayer share drop draws market regulator's scrutiny, source says (Reuters)
• Japan PM Delays Revision Of High-Cost Healthcare Benefit After Patient Protests (Pink Sheet)
• CDMO Almac continues expansion spree with new £65M UK oral treatment plant (Fierce Pharma)
• Kenya HIV patients live in fear as US aid freeze strands drugs in warehouse (Reuters)
• Countries, global health groups band together as US aid gaps threaten lives (Reuters)
• WHO starts slimming down in response to US cuts, document shows (Reuters)
• Nigeria steps up fight against Lassa fever outbreak after 98 deaths this year (Reuters)

• Bristol Myers buys out cell therapy partner 2seventy bio (Endpoints)
• Diseased protein degrader shows mixed results in breast cancer trial (STAT)
• Arvinas, Pfizer’s PROTAC data fall short of hype in breast cancer (Endpoints)
• Merck opens billion-dollar facility to make bladder cancer immunotherapy (Endpoints)
• Virtual physical therapy startup Hinge Health files to go public (Endpoints)
• Viking pays $150M to recruit CordenPharma for obesity drug manufacturing saga (Fierce Pharma)
• Roche Absorbs $2.4B Impairment in Overhaul of Spark Gene Therapy Unit (BioSpace)
• Opinion: FDA Faces Challenging Decision on Biomarker-Based Label Restrictions (BioSpace)

• New Flagship startup aims to trailblaze ‘AI science factories’ (Endpoints)
• Douglas Kelly, deputy science director at FDA’s device center, leaves agency (MedTech Dive)
• ECRI warns insufficient AI governance threatens patient safety (MedTech Dive)
• HIMSS 2025: Interview with Aneesh Chopra, Arcadia’s Chief Strategy Officer, About The Future Of Health Data, Interoperability, AI (MedTech Insight)
• European Health Data Space: Commission And Industry’s Key Principles And Priorities (MedTech Insight)

• Life sciences preprint servers have grown up — and are setting out on their own (STAT)
• Five years of Covid exacted a terrible toll. Another epidemic has claimed even more lives (STAT)
• Trump administration plans to restrict Obamacare enrollment period (Reuters)
• EMA Calls For Accurate Data In CTIS To Improve Visibility On Clinical Trials Map (Pink Sheet)